1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Motion Sickness Treatment Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Motion Sickness Treatment Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Motion Sickness Treatment Market - Breakup by Treatment Type
6.1 Antihistamines
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Anticholinergics
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Others
6.3.1 Historical and Current Market Trends (2018-2023)
6.3.2 Market Forecast (2024-2032)
6.4 Attractive Investment Proposition by Treatment Type
7 Global Motion Sickness Treatment Market - Breakup by Distribution Channel
7.1 Drug Store and Retail Pharmacies
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Online Pharmacies
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Others
7.3.1 Historical and Current Market Trends (2018-2023)
7.3.2 Market Forecast (2024-2032)
7.4 Attractive Investment Proposition by Distribution Channel
8 Global Motion Sickness Treatment Market – Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Drivers
8.1.1.2 Historical and Current Market Trends (2018-2023)
8.1.1.3 Market Breakup by Treatment Type
8.1.1.4 Market Breakup by Distribution Channel
8.1.1.5 Key Players
8.1.1.6 Market Forecast (2024-2032)
8.1.2 Canada
8.1.2.1 Market Drivers
8.1.2.2 Historical and Current Market Trends (2018-2023)
8.1.2.3 Market Breakup by Treatment Type
8.1.2.4 Market Breakup by Distribution Channel
8.1.2.5 Key Players
8.1.2.6 Market Forecast (2024-2032)
8.2 Europe
8.2.1 Germany
8.2.1.1 Market Drivers
8.2.1.2 Historical and Current Market Trends (2018-2023)
8.2.1.3 Market Breakup by Treatment Type
8.2.1.4 Market Breakup by Distribution Channel
8.2.1.5 Key Players
8.2.1.6 Market Forecast (2024-2032)
8.2.2 France
8.2.2.1 Market Drivers
8.2.2.2 Historical and Current Market Trends (2018-2023)
8.2.2.3 Market Breakup by Treatment Type
8.2.2.4 Market Breakup by Distribution Channel
8.2.2.5 Key Players
8.2.2.6 Market Forecast (2024-2032)
8.2.3 United Kingdom
8.2.3.1 Market Drivers
8.2.3.2 Historical and Current Market Trends (2018-2023)
8.2.3.3 Market Breakup by Treatment Type
8.2.3.4 Market Breakup by Distribution Channel
8.2.3.5 Key Players
8.2.3.6 Market Forecast (2024-2032)
8.2.4 Italy
8.2.4.1 Market Drivers
8.2.4.2 Historical and Current Market Trends (2018-2023)
8.2.4.3 Market Breakup by Treatment Type
8.2.4.4 Market Breakup by Distribution Channel
8.2.4.5 Key Players
8.2.4.6 Market Forecast (2024-2032)
8.2.5 Spain
8.2.5.1 Market Drivers
8.2.5.2 Historical and Current Market Trends (2018-2023)
8.2.5.3 Market Breakup by Treatment Type
8.2.5.4 Market Breakup by Distribution Channel
8.2.5.5 Key Players
8.2.5.6 Market Forecast (2024-2032)
8.2.6 Others
8.2.6.1 Historical and Current Market Trends (2018-2023)
8.2.6.2 Market Forecast (2024-2032)
8.3 Asia Pacific
8.3.1 China
8.3.1.1 Market Drivers
8.3.1.2 Historical and Current Market Trends (2018-2023)
8.3.1.3 Market Breakup by Treatment Type
8.3.1.4 Market Breakup by Distribution Channel
8.3.1.5 Key Players
8.3.1.6 Market Forecast (2024-2032)
8.3.2 Japan
8.3.2.1 Market Drivers
8.3.2.2 Historical and Current Market Trends (2018-2023)
8.3.2.3 Market Breakup by Treatment Type
8.3.2.4 Market Breakup by Distribution Channel
8.3.2.5 Key Players
8.3.2.6 Market Forecast (2024-2032)
8.3.3 India
8.3.3.1 Market Drivers
8.3.3.2 Historical and Current Market Trends (2018-2023)
8.3.3.3 Market Breakup by Treatment Type
8.3.3.4 Market Breakup by Distribution Channel
8.3.3.5 Key Players
8.3.3.6 Market Forecast (2024-2032)
8.3.4 South Korea
8.3.4.1 Market Drivers
8.3.4.2 Historical and Current Market Trends (2018-2023)
8.3.4.3 Market Breakup by Treatment Type
8.3.4.4 Market Breakup by Distribution Channel
8.3.4.5 Key Players
8.3.4.6 Market Forecast (2024-2032)
8.3.5 Australia
8.3.5.1 Market Drivers
8.3.5.2 Historical and Current Market Trends (2018-2023)
8.3.5.3 Market Breakup by Treatment Type
8.3.5.4 Market Breakup by Distribution Channel
8.3.5.5 Key Players
8.3.5.6 Market Forecast (2024-2032)
8.3.6 Indonesia
8.3.6.1 Market Drivers
8.3.6.2 Historical and Current Market Trends (2018-2023)
8.3.6.3 Market Breakup by Treatment Type
8.3.6.4 Market Breakup by Distribution Channel
8.3.6.5 Key Players
8.3.6.6 Market Forecast (2024-2032)
8.3.7 Others
8.3.7.1 Historical and Current Market Trends (2018-2023)
8.3.7.2 Market Forecast (2024-2032)
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Drivers
8.4.1.2 Historical and Current Market Trends (2018-2023)
8.4.1.3 Market Breakup by Treatment Type
8.4.1.4 Market Breakup by Distribution Channel
8.4.1.5 Key Players
8.4.1.6 Market Forecast (2024-2032)
8.4.2 Mexico
8.4.2.1 Market Drivers
8.4.2.2 Historical and Current Market Trends (2018-2023)
8.4.2.3 Market Breakup by Treatment Type
8.4.2.4 Market Breakup by Distribution Channel
8.4.2.5 Key Players
8.4.2.6 Market Forecast (2024-2032)
8.4.3 Others
8.4.3.1 Historical and Current Market Trends (2018-2023)
8.4.3.2 Market Forecast (2024-2032)
8.5 Middle East and Africa
8.5.1 Market Drivers
8.5.2 Historical and Current Market Trends (2018-2023)
8.5.3 Market Breakup by Treatment Type
8.5.4 Market Breakup by Distribution Channel
8.5.5 Market Breakup by Country
8.5.6 Key Players
8.5.7 Market Forecast (2024-2032)
8.6 Attractive Investment Proposition by Region
9 Global Motion Sickness Treatment Market – Competitive Landscape
9.1 Overview
9.2 Market Structure
9.3 Market Share by Key Players
9.4 Market Player Positioning
9.5 Top Winning Strategies
9.6 Competitive Dashboard
9.7 Company Evaluation Quadrant
10 Profiles of Key Players
10.1 DM Pharma Marketing Pvt Ltd
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Pfizer Inc.
10.2.1 Business Overview
10.2.2 Product Portfolio
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Prestige Consumer Healthcare Inc.
10.3.1 Business Overview
10.3.2 Product Portfolio
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Reliefband Technologies LLC
10.4.1 Business Overview
10.4.2 Product Portfolio
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Teva Pharmaceutical Industries Ltd.
10.5.1 Business Overview
10.5.2 Product Portfolio
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
10.6 WellSpring Pharmaceutical Corporation
10.6.1 Business Overview
10.6.2 Product Portfolio
10.6.3 Business Strategies
10.6.4 SWOT Analysis
10.6.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
11 Global Motion Sickness Treatment Market - Industry Analysis
11.1 Drivers, Restraints, and Opportunities
11.1.1 Overview
11.1.2 Drivers
11.1.3 Restraints
11.1.4 Opportunities
11.1.5 Impact Analysis
11.2 Porters Five Forces Analysis
11.2.1 Overview
11.2.2 Bargaining Power of Buyers
11.2.3 Bargaining Power of Suppliers
11.2.4 Degree of Competition
11.2.5 Threat of New Entrants
11.2.6 Threat of Substitutes
11.3 Value Chain Analysis
12 Strategic Recommendations
13 Appendix